ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreThe No Surprises Act IDR process continues during the shutdown; timelines apply, portal is active, but CMS responses may be delayed.
The No Surprises Act Independent Dispute Resolution (IDR) process is not affected by the government shutdown. IDR entities are government contractors and as such, continue to process disputes; all standard dispute timelines continue to apply. The Federal IDR portal is also operational, allowing disputing parties to continue to submit claims. CMS responses to IDR complaints and inquiries may be delayed.
For more information, contact Katie Keysor, ACR® Senior Director of Economics and Health Policy.
ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreAC Update Regards Lung Diseases
Stay current with ACR Appropriateness Criteria updates featuring new and revised guidance for lung disease imaging.
Read moreFY27 NIH Appropriations
ACR urges Congress to finalize FY27 NIH funding, protecting biomedical research, medical innovation and advances in patient care.
Read more